Japan Insulin Infusion Pumps Market Insight
Published: 09 June 2026 | Report Format: Electronic (PDF)
The Japan insulin infusion pumps market is projected to grow at a CAGR of 5.7%, driven by rising diabetes prevalence, an aging population, increasing CSII therapy adoption, supportive healthcare coverage, and advancements in smart CGM-integrated insulin pumps
Japan Insulin Infusion Pumps Market Insights Forecasts to 2035
- USD 331.2 Million in 2024 The Japan Insulin Infusion Pumps Market Size Was Estimated at
- 5.7% from 2025 to 2035 The Market Size is Expected to Grow at a CAGR of around
- USD 545.5 Million by 2035 The Japan Insulin Infusion Pumps Market Size is Expected to Rise Around
Notable Insights for the Japan Insulin Infusion Pumps Market
- Based on the Segmentation by Product Type, it can be observed that the Tethered Insulin Pumps & Patch Pumps segment is taking the lead in the Japan Insulin Infusion Pumps Market in 2025, holding approximately 54% of the total market share. This dominance is driven by strong patient preference for tethered pumps in clinical settings and growing interest in wearable patch pumps for home-based diabetes self-management.
- Based on the Segmentation by End User, Hospitals and Clinics held a market share of about 58% in the Japan Insulin Infusion Pumps Market in 2025, mainly driven by the increasing number of type 1 and insulin-dependent type 2 diabetes patients receiving structured care at specialist facilities and the growing coverage of insulin pump therapy under Japan's national health insurance program.
- The global revenue of Medtronic plc in fiscal year 2025 stood at nearly USD 32.3 billion, backed by the continued adoption of its MiniMed 780G hybrid closed-loop insulin pump system across multiple global markets, including Japan's expanding diabetes management sector.
Download the eBook (ToC)
- Increasing investments in AI-integrated insulin delivery, smart sensor-embedded pumps, and digital health monitoring ecosystems will fuel market growth in coming years, as next-generation insulin pump technology enhances glucose control precision by up to 38% and reduces hypoglycemia events by up to 24% compared to traditional multiple daily injection therapy.
What Makes Decisions Advisors Research Unique?
Intelligent Market Research Based on AI & Healthcare Industry
Decisions Advisors offers intelligent market research which includes advanced analysis of insulin delivery technologies, continuous glucose monitoring integration, AI-driven closed-loop insulin systems, and diabetes device regulations. Our research identifies potential areas of business development, technology adoption rates, competitive positioning analysis, and important strategic shifts in the Japan Insulin Infusion Pumps Market.
Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry expert consultations, healthcare value chain tracking, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology roadmapping. The study examines the demand for insulin delivery solutions across hospitals, ambulatory care centers, homecare settings, and diabetes specialty clinics in Japan.
Highly Competitive Environment Analysis
In-depth analysis of key insulin pump manufacturers, medical device innovations, AI-enabled diabetes management solutions, product launch activities, and strategic collaborations is included in the report. The report also covers Japan's medical device regulations administered by the Pharmaceuticals and Medical Devices Agency (PMDA), technology research and development analysis, smart infusion infrastructure, and new growth opportunities available in the Japan Insulin Infusion Pumps Market.
Competitive Analysis
The report offers the appropriate analysis of the key organizations and companies involved within the Japan Insulin Infusion Pumps Market, along with a comparative evaluation primarily based on their product offerings, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Insulin Infusion Pumps Market
- Medtronic Japan Co., Ltd.
- Insulet Corporation (Omnipod)
- Tandem Diabetes Care, Inc.
- Terumo Corporation
- Nipro Corporation
- Roche Diabetes Care Japan Co., Ltd.
- Ypsomed AG
- Abbott Japan LLC
- Dexcom Japan LLC
- Ascensia Diabetes Care Japan K.K.
Recent Developments
- In September 2025, Nipro Corporation launched a national clinical study in Japan for its implantable insulin infusion micro-pump specifically designed for type 1 diabetes patients. The device incorporates a refillable insulin reservoir and a wireless recharging system, marking a significant step toward next-generation implantable insulin delivery in Japan.
- In July 2025, Terumo Corporation announced ongoing research and development efforts on a subcutaneous implantable insulin system capable of delivering ultra-precise micro-doses of insulin, aimed at reducing post-meal glucose spikes and improving overall glycemic control for Japanese diabetes patients.
Market Segmentation
Japan Insulin Infusion Pumps Market, By Product Type
- Tethered Insulin Pumps
- Patch Pumps (Tubeless)
- Implantable Insulin Pumps
- Insulin Pump Infusion Sets
- Insulin Pump Reservoirs & Accessories
Japan Insulin Infusion Pumps Market, By Technology
- Hybrid Closed-Loop Insulin Delivery Systems
- AI-Integrated Smart Insulin Pump Platforms
- Continuous Subcutaneous Insulin Infusion (CSII) Systems
- CGM-Integrated Automated Insulin Delivery Systems
- Predictive Low Glucose Management (PLGM) Technologies
Japan Insulin Infusion Pumps Market, By End User
- Hospitals and Specialty Diabetes Clinics
- Ambulatory Surgical and Outpatient Centers
- Homecare Settings
- Academic and Research Institutions
- Others
Expert View
The Japan insulin infusion pumps market will experience steady and sustained growth owing to the growing burden of diabetes across an aging population, expanding national health insurance coverage for CSII therapy, and surging demand for patient-friendly, wearable insulin delivery solutions. The convergence of artificial intelligence-driven closed-loop insulin systems, continuous glucose monitoring integration, and cloud-enabled remote patient monitoring platforms will significantly enhance therapeutic outcomes and drive broader adoption across hospitals, homecare settings, and diabetes specialty centers in Japan. Additionally, Japan's strong medical device manufacturing base and increasing collaboration between domestic players like Terumo and Nipro with global innovators will further accelerate technology development and market penetration across all major regions of the country.
Author: Sanket and Pranali By Spherical Insights and Consulting